Tau pathology is tightly coupled to neurodegeneration and cognitive impairment in Alzheimer disease (Ossenkoppele et al., 2019), and studies show that advancing tau pathology degrades higher level cognitive functions in patients with AD (Bocancea et al., 2023). Here, MAPT is linked to Alzheimer disease.